UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Cell, 2016-03, Vol.165 (1), p.35-44

2016

Link zum Volltext

Verfügbarkeit prüfen

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Cell reports (Cambridge), 2017-05, Vol.19 (6), p.1189-1201

2017

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Cell, 2017-01, Vol.168 (3), p.542-542

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Nature communications, 2021-11, Vol.12 (1), p.6938-6938, Article 6938

2021

Link zum Volltext

Verfügbarkeit prüfen

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Nature communications, 2014-12, Vol.5 (1), p.5712-5712, Article 5712

2014

Link zum Volltext

Verfügbarkeit prüfen

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

Cancer discovery, 2014-01, Vol.4 (1), p.80-93

2014

Link zum Volltext

Verfügbarkeit prüfen

Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction

Cancer cell, 2015-02, Vol.27 (2), p.240-256

2015

Link zum Volltext

Verfügbarkeit prüfen

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Cell reports (Cambridge), 2019-12, Vol.29 (11), p.3766-3766

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments

Frontiers in immunology, 2022-10, Vol.13, p.1065937

2022

Link zum Volltext

Verfügbarkeit prüfen

Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis

Cancer discovery, 2014-04, Vol.4 (4), p.423-433

2014

Link zum Volltext

Verfügbarkeit prüfen

Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity

The Journal of clinical investigation, 2022-08, Vol.132 (16)

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

The Journal of clinical investigation, 2023-09, Vol.133 (17), p.1-17

2023

Link zum Volltext

Verfügbarkeit prüfen

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Frontiers in immunology, 2023-06, Vol.14, p.1176994-1176994

2023

Link zum Volltext

Verfügbarkeit prüfen

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors

Nature communications, 2014-05, Vol.5 (1), p.3901, Article 3901

2014

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors

Nature communications, 2016-08, Vol.7 (1), p.12348-10, Article 12348

2016

Link zum Volltext

Verfügbarkeit prüfen

Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects

PloS one, 2021-06, Vol.16 (6), p.e0252597-e0252597

2021

Link zum Volltext

Verfügbarkeit prüfen

Modelo de gestión de la cadena de suministro y la rentabilidad de los principales laboratorios farmacéuticos del Perú

Industrial data, 2020-10, Vol.23 (1), p.53-72

2020

Link zum Volltext

Verfügbarkeit prüfen

Stringent DDI-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactions

BMC systems biology, 2013-12, Vol.7 Suppl 6 (S6), p.S6-S6, Article S6

2013

Link zum Volltext

Verfügbarkeit prüfen

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

Nature communications, 2024-05, Vol.15 (1), p.3882-3882

2024

Link zum Volltext

Verfügbarkeit prüfen

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma

Cell discovery, 2016-09, Vol.2 (1), p.16028-16028, Article 16028

2016

Link zum Volltext

Verfügbarkeit prüfen

A human ACTH-secreting corticotroph tumoroid model

EBioMedicine, 2021-04, Vol.66, p.103294, Article 103294

2021

Link zum Volltext

Verfügbarkeit prüfen

SAT-314 Pituitary and Neuroendocrine Tumors Exhibit Distinct Transcriptomes on Single Cell RNA Sequencing

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors

Pharmacology & therapeutics (Oxford), 2022-12, Vol.240, p.108211-108211, Article 108211

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(167)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments

Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis

Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors

Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors

Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects

Modelo de gestión de la cadena de suministro y la rentabilidad de los principales laboratorios farmacéuticos del Perú

Stringent DDI-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactions

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma

A human ACTH-secreting corticotroph tumoroid model

SAT-314 Pituitary and Neuroendocrine Tumors Exhibit Distinct Transcriptomes on Single Cell RNA Sequencing

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma

The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors

Suchergebnisse filtern